Vaccinex Inc (VCNX)
6.00
+0.06
(+1.01%)
USD |
NASDAQ |
May 01, 16:00
7.75
+1.75
(+29.17%)
After-Hours: 07:10
Vaccinex Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.0308 |
| June 30, 2023 | -0.3262 |
| March 31, 2023 | 0.0654 |
| December 31, 2022 | 0.0337 |
| September 30, 2022 | 0.0305 |
| June 30, 2022 | 0.0194 |
| March 31, 2022 | 0.0142 |
| December 31, 2021 | 0.0336 |
| September 30, 2021 | 0.0954 |
| June 30, 2021 | 0.2139 |
| March 31, 2021 | 4.191 |
| December 31, 2020 | -0.3465 |
| Date | Value |
|---|---|
| September 30, 2020 | -0.4468 |
| June 30, 2020 | -0.0384 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | -0.0454 |
| March 31, 2018 | -0.057 |
| December 31, 2017 | -0.2048 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.4468
Minimum
Sep 2020
4.191
Maximum
Mar 2021
0.1949
Average
0.0071
Median
Debt to Equity Ratio Benchmarks
| Emergent BioSolutions Inc | 1.325 |
| Avinger Inc | -2.305 |
| RAPT Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.631M |
| Total Liabilities (Quarterly) | 5.942M |
| Shareholders Equity (Quarterly) | -2.311M |